Transparency Market Research

Cell-Based Assays Market: Focus on Drug-Based Research Defines Growth Trajectory, Notes TMR

Transparency Market Research Report Added "Cell Based Assays Market" to its database.


Albany, NY -- (SBWIRE) -- 12/06/2016 -- The emergence of new technologies and revolutionary branches of science and medicine has significantly boosted the uptake of cell-based assays. In a report titled "Cell Based Assays Market - Global Industry Analysis, Share, Size, Growth, Trends, and Forecast 2012–2018", Transparency Market Research offers sharp insights into the development of this method and the impact it has had on the process of drug discovery.

It has been noted that the global cell-based assays market is primarily driven by rising expenditure on R&D. In addition to this, the growing usage of cell-based assays in drug discovery, the benefits offered by this method over others, and recent advancements in techniques are anticipated to support the growth of this market. In contrast, hurdles related to intellectual property and the expensive nature of the instruments and devices used threaten to impede growth.

Read Full Report:

The global report on the cell-based assays market offers a lengthy assessment on the various regional segments and sheds light on the key trends prevalent in various countries. By geography, the market is categorized into Asia Pacific, North America, Europe, and Rest of the World. Over the past few years, North America has accounted for a significant share in the worldwide cell-based assays market. This can be attributed the strong presence of major pharmaceutical companies in the U.S. as well as Canada, which are dedicated toward drug-based research and development activities. The market in this region is also fueled by the growing presence of advanced biotechnology laboratories.

Asia Pacific has been identified as a promising market for cell-based assays and countries such as China and India hold immense scope for growth. A large population base and lower labor costs have attracted pharma companies to set up shop in this region and make the most of the conducive environment. Asia Pacific also presents a promising future for contract research organizations since drug discovery in Asian countries has proven to be rather fruitful and cost-effective.

Download exclusive Sample of this Report:

Realizing the potential that cell-based assays presents in a wide range of applications, an increasing number of players are entering the market. PerkinElmer Inc., Cisbio Bioassays, Sigma-Aldrich, DiscoveRx Corp., GE Healthcare Life Sciences, BioVision Inc., Caliper Life Sciences Inc., Promega Corporation, EMD Millipore, Life Technologies, ProQinase GmbH, Thermo Fisher Scientific Inc., Beckman Coulter Inc., Xenometrix AG, and D Biosciences are among the key players vying for a significant share in the cell-based assays market.

The report studies each company in much detail and offers readers sharp and actionable insights into who the key competitors are and how to formulate strategies to gain an advantage. The publication serves as an ideal blueprint on getting ahead in this lucrative market and making the most of the opportunities in store.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453